4//SEC Filing
Lezack Adam 4
Accession 0002048466-25-000005
CIK 0001674632other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:20 PM ET
Size
7.0 KB
Accession
0002048466-25-000005
Insider Transaction Report
Form 4
Lezack Adam
Director
Transactions
- Sale
Common Stock
2025-12-01$29.35/sh−906$26,588→ 8,935 total - Sale
Common Stock
2025-12-01$29.91/sh−500$14,955→ 8,435 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
- [F2]The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048466
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:20 PM ET
- Size
- 7.0 KB